TUMOR-ASSOCIATED ANTIGEN DERIVATIVES FROM THE MAGE FAMILY, AND NUCLEIC ACID SEQUENCES ENCODING THEM, USED FOR THE PREPARATION OF FUSION PROTEINS AND OF COMPOSITIONS FOR VACCINATION
the object of the invention is mage - from u00f6sszef u00fcgg u0151antig u00e9nsz u00e1rmaz u00e9k, tumor, which sz u00e1rmaz u00e9kolt tiolcsoportokat tartalmaz u00f3mage antigen or recombinant, expressed in mage - f u00fazi u00f3sfeh u00e9rje,in which the fusion partner protein or its fragmense d, or the flu ns1 - protein or its fragmense, or astreptococcus origin c pneumoniae or its fragmense lyta.furthermore, the subject of atal u00e1lm u00e1ny antigen coding nucleic acid sequence, a vector containing the vektorral transzform u00e1ltgazdaszervezet, the antig u00e9nfeh u00e9rj u00e9t containing vaccine.the valamintelj u00e1r u00e1sok protein or a derivative thereof, or for the production of the vaccine.solution according to the invention, melan u00f3m u00e1k or other mage with u00f6sszef u00fcgg u0151tumorok treatment and prevention can be used in the field of. ohDen foreliggende oppfinnelse vedrører nye proteiner og deres produksjon, fra MAGE-familien. Spesielt et MAGE-protein koblet til en immunologisk fusjonspartner, slik som Lipoprotein D. Slike antigener kan formuleres for å tilveiebringe vaksiner for behandling, av en rekke av tumorer. Nye metoder for å rense MAGE proteinene er også tilveiebrakt.
